Sunshine Biopharma (SBFM) Total Current Liabilities: 2015-2025
Historic Total Current Liabilities for Sunshine Biopharma (SBFM) over the last 10 years, with Sep 2025 value amounting to $6.7 million.
- Sunshine Biopharma's Total Current Liabilities rose 46.88% to $6.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.7 million, marking a year-over-year increase of 46.88%. This contributed to the annual value of $6.3 million for FY2024, which is 13.74% up from last year.
- Per Sunshine Biopharma's latest filing, its Total Current Liabilities stood at $6.7 million for Q3 2025, which was up 19.33% from $5.6 million recorded in Q2 2025.
- Sunshine Biopharma's 5-year Total Current Liabilities high stood at $6.9 million for Q4 2022, and its period low was $91,229 during Q4 2021.
- Its 3-year average for Total Current Liabilities is $5.7 million, with a median of $5.6 million in 2025.
- Per our database at Business Quant, Sunshine Biopharma's Total Current Liabilities tumbled by 91.32% in 2021 and then spiked by 7,497.38% in 2022.
- Sunshine Biopharma's Total Current Liabilities (Quarterly) stood at $91,229 in 2021, then surged by 7,497.38% to $6.9 million in 2022, then declined by 19.90% to $5.6 million in 2023, then grew by 13.74% to $6.3 million in 2024, then soared by 46.88% to $6.7 million in 2025.
- Its Total Current Liabilities was $6.7 million in Q3 2025, compared to $5.6 million in Q2 2025 and $5.8 million in Q1 2025.